Media & Announcements
Polpharma Group at CPHI Milan 2026: Strengthening Partnerships Across the Global Pharmaceutical Value Chain
At CPHI Milan 2026, a Polpharma delegation led by CEO Sebastian Szymanek met partners on APIs, finished dosage forms, CDMO services and new technologies.
Group News
October 21, 2026
Polpharma at EFNI 2026: Building Innovation, Resilience and Europe’s Future
At EFNI 2026 in Sopot, Polpharma shared its innovation experience and joined debates on resilient supply chains and Europe’s industrial future.
Group News
October 21, 2026
Polpharma strengthens it's position in CEE - Biofarm, the leader of the Romanian market, joins the Group.
Polpharma Group has completed the acquisition of the Romanian pharmaceutical company Biofarm. The transaction is a clear step in the execution of the Group’s growth strategy and strengthens its position in Central and Eastern Europe.
Group News
July 27, 2026
Polpharma Group’s R&D supports growth in key therapeutic areas.
Polpharma Group's research and development capabilities support growth across its key therapeutic areas and strengthen its product pipeline.
Group News
June 26, 2026
Polpharma strengthens it's position in CEE - Biofarm, the leader of the Romanian market, joins the Group.
Polpharma Group has completed the acquisition of the Romanian pharmaceutical company Biofarm. The transaction is a clear step in the execution of the Group’s growth strategy and strengthens its position in Central and Eastern Europe.
Group News
July 27, 2026
.avif)
.avif)
The Leonardo Innovation Program won the Gold Stevie Awards® gold statuette in the 19th edition of the prestigious international competition International Business Awards®!
The Leonardo employee innovation programme wins Gold at the Stevie International Business Awards for creativity, engagement and innovative communication.
Group News
August 16, 2022
Polpharma API completed step 1. Risk Evaluation according to EMA’s request concerning presence of nitrosamines in drug products.
Polpharma completed EMA risk assessment for nitrosamines in chemically synthesised APIs, identifying optimisation parameters for highest quality.
Group News
December 17, 2020
Press releases
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Tender Notices
No items found.
September 6, 2023
Pre-filled syringes filling and packaging line for sale
Polfa Warszawa invites tenders to buy a decommissioned pre-filled syringes filling and packaging line (Groninger filler, labeller, CAM blister).
Tender Notices
No items found.
September 1, 2023
Aseptic ophthalmics filling line including the solution preparation units for sale
Polfa Warszawa invites tenders to buy a decommissioned aseptic ophthalmic liquids filling line including its solution preparation units.
Tender Notices
No items found.
July 10, 2023
Aseptic glass vials filling line for sale
Polfa Warszawa invites tenders to buy a decommissioned 2008 Bosch filling line for glass vials, listed as device number 100019.
Group News
Polpharma API
July 6, 2023
Ryvu Therapeutics and Polpharma sign two agreements in the area of RVU120 active substance (API) production for Phase II clinical trials
Polpharma API manufactures RVU120 for Ryvu Phase II trials treating leukaemia and myelodysplastic syndrome in EUR 1.7 million deals.
Latest stories
featured
.avif)
For the media
Media Kit
Logos, photography and the Group boilerplate.
ZIP file (112.28 kb) updated quarterly
Group factsheet
Revenue, footprint, pipeline, employment and history.
Pdf file (112.28 kb) updated quarterly
Press Contact
Logos, photography and the Group boilerplate.
press@polpharma.com
RESPONDS WITHIN ONE BUSINESS DAY